BARINAT (baricitinib) tablets is used for the treatment of patients with rheumatoid arthritis and COVID-19.

BARINAT (baricitinib) blocks the activity of certain enzymes involved in activating inflammation in the body. BARINAT is used to reduce pain, stiffness, and swelling in adults with rheumatoid arthritis after other treatments have failed. BARINAT also helps slow the progression of bone and joint damage.

In November 2020, the FDA issued an Emergency Use Authorization (EUA) for the combination of baricitinib with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized people two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

BARINAT (baricitinib) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of BARINAT (baricitinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the BARINAT (baricitinib) tablets medicine cost price in India.

The order for BARINAT (baricitinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Baricitinib is a janus kinase inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation. Baricitinib is a prescription oral tablet medication that is FDA-approved (and sold under the brand name BARINAT) for the treatment of moderately to severely active rheumatoid arthritis. Under today’s EUA, the FDA is authorizing the emergency use of baricitinib, in combination with remdesivir, for the treatment of certain hospitalized patients with suspected or laboratory-confirmed COVID-19.

the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Content Source: FDA NEWS RELEASE

BARINAT (baricitinib) tablets, for oral use Initial U.S. Approval: 2018

Generic Name: baricitinib

BARINAT (Baricitinib)

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to BARINAT (Baricitinib) on the Named Patient Import basis in India.

BARINAT (baricitinib) tablets suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand BARINAT (baricitinib) tablets on prescription and Import License in Patient's Name only.

For overseas patients, BARINAT (baricitinib) tablets can be made available in Send your enquiry to find BARINAT (baricitinib) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for BARINAT (baricitinib) tablets.

For BARINAT (baricitinib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Natco rolls out Baricitinib ahead of approval for patent waiver For More Details

Lilly accelerating baricitinib's availability in India following receipt of permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreements For More Details

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur